Crossmark

Pathogenic stromal cells as therapeutic targets in joint inflammation

Crossref DOI link: https://doi.org/10.1038/s41584-018-0112-7

Published Online: 2018-11-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dakin, Stephanie G.

Coles, Mark

Sherlock, Jonathan P.

Powrie, Fiona

Carr, Andrew J.

Buckley, Christopher D.
License Information

Text and Data Mining valid from 2018-11-12
More Information

Article History

First Online: 12 November 2018

Change Date: 29 November 2018

Change Type: Correction

Change Details: In the originally published version of this article, the acknowledgements and affiliations contained errors. In the acknowledgements, “NIHR Oxford and Birmingham Biomedical Research Centres” and “the Department of Health and Social Care” were incorrectly presented as “NIHR Oxford Biomedical Research Centres” and “the Department of Health”. For affiliation 4, “NIHR Birmingham Biomedical Research Centre, University Hospitals Birmingham NHS Foundation Trust and University of Birmingham, Institute of Inflammation and Ageing, Birmingham, UK” was incorrectly presented as “Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK”. For affiliation 3, "Institute" was incorrectly spelt. These errors have now been corrected in the HTML and PDF versions of the manuscript.

Competing interests

: The authors declare no competing interests.